Skip to main content
. 2020 Dec 31;26(1):142. doi: 10.3390/molecules26010142
COVID-19 coronavirus disease 2019
SARS severe acute respiratory syndrome
SARS-CoV-2 severe acute respiratory syndrome coronavirus-2
PHEIC public health emergency of international concern
S-protein spike glycoprotein
ACE2 angiotensin-converting enzyme 2
ACE angiotensin-converting enzyme
RBD receptor-binding domain
cryo-EM cryo-electron microscopy
RAS renin-angiotensin system
Ang I angiotensin I
Ang II angiotensin II
AT1 angiotensin receptor type 1
AT2 angiotensin receptor type 2
ACEIs ACE inhibitors
ARBs AT1 receptor blockers
ARDS acute respiratory distress syndrome
ICU intensive care unit
ADAM-17 ADAM metallopeptidase domain 17
TMPRSS2 Transmembrane Serine Protease 2
AR androgen receptor
DHT dihydrotestosterone
LNCaP activin-sensitive prostate cancer cells
ER endoplasmic reticulum
hESC human embryonic stem cell
PD peptidase domain
NAAE N-(2-aminoethyl)-1 aziridine-ethanamine
IC50 the half maximal inhibitory concentration
KD the calculated affinity
IFN interferon
IL interleukin
ERK extracellular signal-regulated kinase
JNK c-Jun N-terminal kinase
IPF idiopathic pulmonary fibrosis
PAH pulmonary arterial hypertension
ALI acute lung injury
LPS lipopolysaccharide
TLR4 toll-like receptor 4
MAP mitogen-activated protein
ERK/MAPK extracellular-signal-regulated kinase/mitogen-activated protein kinase
NF-κB nuclear factor-κB
AMPA alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
APJ the apelin receptor
SIRT1 Sirtuin 1
AMPK AMP-activated protein kinase
T2DM Type 2 diabetes mellitus
ISG interferon stimulated gene
fMLP N-formylmethionyl-leucyl-phenylalanine
MAS1 the G protein-coupled receptor Mas